NEW YORK (GenomeWeb) – Sysmex Inostics today announced that it has signed an exclusive distribution agreement with IndivuTest for the OncoBEAM test.

Under the terms of the agreement, IndivuTest will offer Sysmex Inostics' OncoBEAM laboratory-based test throughout Germany, Austria, and Switzerland. IndivuTest will be responsible for commercial and sample logistics, while Sysmex Inostics will perform all testing services at its CLIA laboratory in Baltimore.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more